Año: 2022
Journal Impact Factor (JIF): 4.90
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| GASTROENTEROLOGY & HEPATOLOGY | SCIE | 28/93 | Q2 | T1 | D3 |
Año: 2022
Journal Citation Indicator (JCI): 1,140
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| GASTROENTEROLOGY & HEPATOLOGY | 25/139 | Q1 | T1 | D2 | 82,37 |
Año:
2022
CiteScore:
10,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Gastroenterology | 14/149 | Q1 | T1 | D1 |
| Immunology and Allergy | 41/211 | Q1 | T1 | D2 |
SJR año:
2022
Factor de Impacto:
1,834
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Gastroenterology | 15/164 | Q1 | T1 | D1 |
| Immunology and Allergy | 33/226 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Takeda Pharmaceuticals International Co. | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | IDIBAPS (Spain) | |
| 2 | Bouma, G | University of Amsterdam (Netherlands) |
| 3 | Ferrante, M | University Hospital Leuven (Belgium) |
| 4 | Kucharzik, T | University of Hamburg (Germany) |
| 5 | Nachury, M | Université de Lille (France) |
| 6 | de la Portilla de Juan, F | Takeda Pharmaceuticals International, Inc. (Switzerland) |
| 7 | Reinisch, W | McMaster University; Medical University of Vienna (Canada) |
| 8 | Selvaggi, F | Universita della Campania Vanvitelli (Italy) |
| 9 | Tschmelitsch, J | Konventhospital Der Barmherzigen Bruder (Austria) |
| 10 | Brett, NR | Evidera (Canada) |
| 11 | Ladouceur, M | Evidera (Canada) |
| 12 | Binek, M | Sin datos () |
| 13 | Hantsbarger, G | Takeda Pharmaceut Co Ltd (USA) |
| 14 | Campbell-Hill, S | Takeda Development Centre Europe Ltd. (England) |
| 15 | Karki, C | Takeda Pharmaceut Co Ltd (USA) |
| 16 | Buskens, C | University of Amsterdam (Netherlands) |
